Added to YB: 2025-04-09
Pitch date: 2025-04-07
GKOS [bullish]
Glaukos Corporation
+20.54%
current return
Author Info
No bio for this author
Company Info
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.
Market Cap
$5.2B
Pitch Price
$90.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
-102.02
P/E
-58.28
EV/Sales
10.65
Sector
Health Care Equipment and Supplies
Category
growth
ClearBridge Small Cap Growth Strategy New Position: Glaukos Corporation
GKOS (new position): Ophthalmology med device co. w/ commercialized products & innovative track record. Launching potential blockbuster iDose, drug-device combo for glaucoma w/ admin/efficacy advantages. Focus on glaucoma & corneal health treatments.
Read full article (1 min)